Mattia Cocco

Mattia Cocco is an Associate Director at AstraZeneca, where they are actively involved in the development of next-generation Antibody-Drug Conjugates for the oncology portfolio. With a background as a medicinal chemist, Mattia has expertise in drug discovery for oncology and neglected tropical diseases, including targeted delivery methods like ADCs, PROTACs, and covalent inhibitors. Previously, Mattia served as a Senior Scientist and Medicinal Chemist at AstraZeneca and the University of Dundee, respectively. Mattia earned a PhD in Medicinal and Pharmaceutical Chemistry from Università degli Studi di Torino.